Select Year
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
MENU
Strategic Plan Questions
Funders
Federal vs. Private
Strategic Plan Multiyear Funding
Strategic Plan Objectives
Subcategories
Geography
About
Question 4: Short-term Objective B
Q4.S.B : Standardize and validate at least 20 model systems (e.g., cellular and/or animal) that replicate features of ASD and will allow identification of specific molecular targets or neural circuits amenable to existing or new interventions by 2012.
Projects Found: 102
Total Funding: $17,006,996
Display
10
20
30
Records
Department of Defense - Army
Novel therapeutic targets to treat social behavior deficits in autism and related disorders
$0
$0
University of Texas Health Science Center, San Antonio
Autism Science Foundation
Endocannabanoid Enhancement of Sociability in Autism-related Mouse Models
$25,000
$25,000
University of California, Irvine
Autism Speaks
Mechanism and treatment of ASD related behavior in the Cntnap2 knockout mouse model
$0
$0
University of California, Los Angeles
Autism Speaks
Preclinical Autism Consortium for Therapeutics (PACT)
$389,677
$389,677
University of California, Davis
Autism Speaks
Novel approaches to enhance social cognition by stimulating central oxytocin release
$149,665
$149,665
Emory University
Autism Speaks
Preclinical Autism Consortium for Therapeutics (PACT)- Boston Children's Hospital
$316,301
$316,301
Boston Children's Hospital
Autism Speaks
Identifying high-impact therapeutic targets for autism spectrum disorders using rat models
$0
$0
Mount Sinai School of Medicine
Autism Speaks
Effects of oxytocin receptor agonists in mouse models of autism spectrum disorder phenotypes
$0
$0
University of North Carolina
Autism Speaks
Evaluating hyperserotonemia as a biomarker of sensory dysfunction in autism spectrum
disorder
$0
$0
Vanderbilt University
Autism Speaks
Preclinical therapeutic target validation of glutamate receptors in Shank3 models of autism
$0
$0
University of Texas Southwestern Medical Center